ArticleFrontiers in endocrinology2023

CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.

Jaime M Pita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.